Over the last 7 days, the Pharma industry has risen 1.9%, driven by gains from Eli Lilly of 5.1%. Meanwhile, Bristol-Myers Squibb actually underperformed within the industry, shrinking 5.1% in the last week. This takes the industry's 12 month performance to a gain of 17%. As for the next few years, earnings are expected to grow by 24% per annum.
Has the U.S. Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 23 May 2024 | US$1.9t | US$358.3b | US$14.1b | 18.3x | 133.6x | 5.2x |
Sat, 20 Apr 2024 | US$1.8t | US$357.7b | US$29.8b | 20.3x | 60.2x | 5x |
Mon, 18 Mar 2024 | US$1.9t | US$355.4b | US$22.5b | 19.8x | 82.7x | 5.2x |
Wed, 14 Feb 2024 | US$1.8t | US$354.9b | US$22.8b | 31x | 80.9x | 5.2x |
Fri, 12 Jan 2024 | US$1.8t | US$375.2b | US$33.9b | 26.6x | 52.4x | 4.7x |
Sun, 10 Dec 2023 | US$1.7t | US$375.1b | US$33.9b | 26.6x | 48.9x | 4.4x |
Tue, 07 Nov 2023 | US$1.6t | US$376.9b | US$33.9b | 18.9x | 48.1x | 4.3x |
Thu, 05 Oct 2023 | US$1.6t | US$381.8b | US$43.8b | 18.5x | 37.6x | 4.3x |
Sat, 02 Sep 2023 | US$1.7t | US$381.4b | US$43.7b | 19.6x | 39.7x | 4.5x |
Mon, 31 Jul 2023 | US$1.7t | US$393.6b | US$61.5b | 18.5x | 28x | 4.4x |
Wed, 28 Jun 2023 | US$1.7t | US$392.8b | US$60.1b | 18.9x | 29x | 4.4x |
Fri, 26 May 2023 | US$1.7t | US$392.9b | US$60.5b | 18.3x | 28.1x | 4.3x |
Sun, 23 Apr 2023 | US$1.7t | US$402.6b | US$63.3b | 17.8x | 26.3x | 4.1x |
Tue, 21 Mar 2023 | US$1.6t | US$401.1b | US$69.3b | 15.6x | 22.5x | 3.9x |
Thu, 16 Feb 2023 | US$1.6t | US$401.8b | US$68.4b | 18.6x | 24.1x | 4.1x |
Sat, 14 Jan 2023 | US$1.7t | US$403.7b | US$70.6b | 17.6x | 24.6x | 4.3x |
Mon, 12 Dec 2022 | US$1.8t | US$403.7b | US$70.7b | 16.5x | 24.8x | 4.3x |
Wed, 09 Nov 2022 | US$1.7t | US$403.8b | US$71.4b | 14.9x | 23.6x | 4.2x |
Fri, 07 Oct 2022 | US$1.6t | US$403.0b | US$71.3b | 12.4x | 22x | 3.9x |
Sun, 04 Sep 2022 | US$1.6t | US$403.0b | US$71.3b | 14.6x | 21.8x | 3.9x |
Tue, 02 Aug 2022 | US$1.7t | US$405.2b | US$69.7b | 21.3x | 23.8x | 4.1x |
Thu, 30 Jun 2022 | US$1.7t | US$392.6b | US$64.9b | 21.2x | 25.9x | 4.3x |
Sat, 28 May 2022 | US$3.4t | US$414.0b | US$71.9b | 23.3x | 47.2x | 8.2x |
Mon, 25 Apr 2022 | US$1.6t | US$374.9b | US$59.9b | 21.4x | 27.2x | 4.3x |
Wed, 23 Mar 2022 | US$1.6t | US$373.7b | US$60.3b | 20.9x | 27.1x | 4.4x |
Fri, 18 Feb 2022 | US$1.5t | US$373.4b | US$59.2b | 21x | 26.1x | 4.1x |
Sun, 16 Jan 2022 | US$1.6t | US$361.3b | US$37.7b | 24.3x | 42.4x | 4.4x |
Tue, 14 Dec 2021 | US$1.6t | US$361.1b | US$38.1b | 21.9x | 41.5x | 4.4x |
Thu, 11 Nov 2021 | US$1.6t | US$360.4b | US$38.3b | 24.2x | 41.8x | 4.4x |
Sat, 09 Oct 2021 | US$1.5t | US$337.7b | US$24.8b | 19.4x | 60.1x | 4.4x |
Mon, 06 Sep 2021 | US$1.6t | US$338.7b | US$25.4b | 17.7x | 62.8x | 4.7x |
Wed, 04 Aug 2021 | US$1.6t | US$338.5b | US$25.8b | 20.5x | 61.1x | 4.7x |
68.9x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 1.25% | |
Healthcare | 1.13% | |
Pharma | 1.93% | |
Pharma | 1.93% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
LLY Eli Lilly | US$802.91 | 2.0% +US$14.3b | 88.6% | PE117.8x | |
PFE Pfizer | US$29.60 | 2.7% +US$4.4b | -23.4% | PS3.1x | |
JNJ Johnson & Johnson | US$153.50 | 0.5% +US$2.0b | -2.0% | PE21.6x | |
ARVN Arvinas | US$35.95 | 11.2% +US$247.7m | 49.8% | PS34.5x | |
AKAN Akanda | US$3.66 | -11.9% US$247.2m | -89.5% | PS130x |